How to Choose Acceptable Tablet Formulations in Psychiatric Outpatients
How should clinicians use tablet shape, size, and color preferences when choosing oral psychiatric medications for outpatients?
Patients often react to how a tablet looks and feels before they ever judge whether it helps. This guide applies when clinicians are choosing among clinically equivalent oral tablet options and want to improve acceptability without expecting formulation esthetics alone to solve adherence problems.
-
Ask about tablet attribute preferences and dislikes
Elicit whether the patient prefers or dislikes basic tablet attributes such as shape, size, and color. The study specifically evaluated flat circular versus oval or oblong shapes, small versus medium versus large size, and white, yellow, red, or blue color categories.
-
Favor more acceptable options when choices are otherwise equivalent
If clinically equivalent oral formulations are available, consider options aligned with the most common preferences in the study: oval or oblong shape, small size, and white color. These were preferred by 43.5%, 41.4%, and 41.8% of patients, respectively.
-
Avoid commonly disliked tablet features when feasible
When there is flexibility in product selection, try to avoid attributes that patients most often disliked, especially large tablets, flat-circular tablets, and red tablets. In the study, these were disliked by 53.4%, 40.5%, and 33.6% of patients, respectively.
-
Set expectations that acceptability is not the same as adherence
Explain to patients and care teams that tablet esthetics may matter for acceptability, but this study did not find that preferences or dislikes significantly predicted adherence. All associations between tablet attributes and adherence were nonsignificant, with P values greater than .05 and small effect sizes.
-
Pair formulation choice with broader adherence interventions
Use formulation acceptability as a secondary aid, not a primary adherence strategy. The article supports integrated interventions such as psychoeducation on formulations, cognitive-behavioral strategies, and attention to psychosocial barriers, particularly in groups with low insight.
Clinical Considerations
- The study found no significant association between tablet preferences or dislikes and medication adherence.
- These preference data come from a single urban Indian outpatient sample and may not generalize to other settings or populations.
- The findings apply to solid oral dosage forms and do not establish that changing formulation appearance improves long-term adherence.
- Adherence outcomes were based on self-report rather than objective adherence measures.
Bottom Line
When equivalent tablet options exist, choose more acceptable shapes, sizes, and colors for patient comfort, but do not expect esthetic changes alone to improve adherence.
